These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6125187)

  • 1. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
    Rangno RE; Langlois S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
    Rangno RE; Langlois S
    Am Heart J; 1982 Aug; 104(2 Pt 2):473-8. PubMed ID: 7102534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt withdrawal of pindolol or metoprolol after chronic therapy.
    Szécsi E; Kohlschütter S; Schiess W; Lang E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):353S-357S. PubMed ID: 7104154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal.
    Rangno RE; Langlois S; Stewart J
    Clin Pharmacol Ther; 1982 May; 31(5):564-71. PubMed ID: 7075106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol withdrawal phenomena: mechanism and prevention.
    Rangno RE; Langlois S; Lutterodt A
    Clin Pharmacol Ther; 1982 Jan; 31(1):8-15. PubMed ID: 7053309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of beta-blocking drugs.
    Walden RJ; Hernandez J; Yu Y; Al-Khader A; Prichard BN
    Am Heart J; 1982 Aug; 104(2 Pt 2):515-20. PubMed ID: 6125098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease.
    Olsson G; Hjemdahl P; Rehnqvist N
    Am Heart J; 1984 Sep; 108(3 Pt 1):454-62. PubMed ID: 6475710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes.
    Tygesen H; Andersson B; Di Lenarda A; Rundqvist B; Sinagra G; Hjalmarson A; Waagstein F; Wennerblom B
    Int J Cardiol; 1999 Feb; 68(2):171-7. PubMed ID: 10189005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
    Walden RJ; Tomlinson B; Graham B; Liu JB; Prichard BN
    Br J Clin Pharmacol; 1990 Oct; 30(4):557-65. PubMed ID: 1981318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule.
    Rangno RE; Nattel S; Lutterodt A
    Am J Cardiol; 1982 Mar; 49(4):828-33. PubMed ID: 6278914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic hypersensitivity after beta-blocker withdrawal.
    Ross PJ; Lewis MJ; Sheridan DJ; Henderson AH
    Br Heart J; 1981 Jun; 45(6):637-42. PubMed ID: 6114739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
    Krukemyer JJ; Boudoulas H; Binkley PF; Lima JJ
    Am Heart J; 1990 Sep; 120(3):572-9. PubMed ID: 2389694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
    Brynne L; Paalzow LK; Karlsson MO
    J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.
    Kiyingi KS; Shaw J
    Eur J Clin Pharmacol; 1984; 27(4):423-8. PubMed ID: 6097455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.